Courtney Breen on Tariffs’ Impact

Courtney Breen, Senior Research Analyst at Bernstein, asserts that current tariffs have a negligible effect on the pharmaceutical industry.

Zepbound’s Market Growth

Breen highlights that Zepbound is quickly increasing its market share in the obesity drug sector, indicating a positive trend for the product.

Amgen’s Earnings Outlook

Despite mixed earnings reports, Breen identifies Amgen as her top investment choice, reflecting confidence in the company’s future performance.